The Exchange has sought clarification from Concord Drugs Ltd on July 2, 2025, with reference to Movement in Price<BR><BR>The reply is awaited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 3.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The BSE has asked Concord Drugs Ltd to explain a recent unusual movement in its share price, with the query raised on July 2, 2025. The company has not yet submitted its response, and the reply is awaited. This is a routine regulatory step the exchange takes when it notices abnormal trading activity, asking the company whether any undisclosed corporate information could have triggered the move. Until the company responds, the reason behind the price action remains officially unexplained.
Shareholders should watch for the company's clarification, as the response could reveal material information or confirm no undisclosed developments. In the short term, the lack of clarity may keep the stock volatile or under scrutiny.